➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Harvard Business School
Boehringer Ingelheim
McKinsey
Colorcon

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

PROPANTHELINE BROMIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Propantheline Bromide, and what generic alternatives are available?

Propantheline Bromide is a drug marketed by Ascot, Heather, Hikma, Impax Labs, Mylan, Par Pharm, Pvt Form, Sandoz, Tablicaps, and Watson Labs. and is included in eleven NDAs.

The generic ingredient in PROPANTHELINE BROMIDE is propantheline bromide. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the propantheline bromide profile page.

US ANDA Litigation and Generic Entry Outlook for Propantheline Bromide

A generic version of PROPANTHELINE BROMIDE was approved as propantheline bromide by HIKMA on December 31st, 1969.

  Start Trial

Drug patent expirations by year for PROPANTHELINE BROMIDE
Recent Clinical Trials for PROPANTHELINE BROMIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Hospital Universitário Professor Edgard SantosPhase 1
Chongqing Medical UniversityPhase 4

See all PROPANTHELINE BROMIDE clinical trials

Pharmacology for PROPANTHELINE BROMIDE
Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Medical Subject Heading (MeSH) Categories for PROPANTHELINE BROMIDE

US Patents and Regulatory Information for PROPANTHELINE BROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ascot PROPANTHELINE BROMIDE propantheline bromide TABLET;ORAL 087663-001 Oct 25, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Par Pharm PROPANTHELINE BROMIDE propantheline bromide TABLET;ORAL 088377-001 Dec 8, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Hikma PROPANTHELINE BROMIDE propantheline bromide TABLET;ORAL 080927-002 Approved Prior to Jan 1, 1982 RX No Yes   Start Trial   Start Trial   Start Trial
Watson Labs PROPANTHELINE BROMIDE propantheline bromide TABLET;ORAL 083151-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Express Scripts
Merck
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.